Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADH. (Q41681058)

7 October 2017

Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADH. (English)

1 reference

7 October 2017

David B Dunger

7

0 references

author name string

Ruben H Willemsen

1

1 reference

7 October 2017

Violeta Delgado-Carballar

2

1 reference

7 October 2017

Daniela Elleri

3

1 reference

7 October 2017

Ajay Thankamony

4

1 reference

7 October 2017

G A Amos Burke

5

1 reference

7 October 2017

James C Nicholson

6

1 reference

7 October 2017

1 November 2016

1 reference

Endocrinology, diabetes & metabolism case reports

7 October 2017

1 reference

7 October 2017

2016

1 reference

Tolvaptan is successful in treating inappropriate antidiuretic hormone secretion in infants

7 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Evidence for the use of demeclocycline in the treatment of hyponatraemia secondary to SIADH: a systematic review

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Evaluation and management of hyponatraemia in children

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Clinical practice guideline on diagnosis and treatment of hyponatraemia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Tolvaptan therapy for massive edema in a patient with nephrotic syndrome

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Vaptans: A new option in the management of hyponatremia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Role of vaptans in the management of hyponatremia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Use of conivaptan to allow aggressive hydration to prevent tumor lysis syndrome in a pediatric patient with large-cell lymphoma and SIADH.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5097145

Effect of the oral vasopressin receptor antagonist tolvaptan on congestive cardiac failure in a child with restrictive cardiomyopathy

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27857840

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tolvaptan increases serum sodium in pediatric patients with heart failure

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27857840

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

0 references

1 reference

7 October 2017

1 reference